We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

60 hedge funds and large institutions have $139M invested in Utah Medical Products in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

16% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 19

12% more capital invested

Capital invested by funds: $124M → $139M (+$14.9M)

9% more funds holding

Funds holding: 55 → 60 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
60
Holders Change
+5
Holders Change %
+9.09%
% of All Funds
1.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
22
Reduced
19
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.58M
2
Renaissance Technologies
Renaissance Technologies
New York
+$731K
3
BFA
BlackRock Fund Advisors
California
+$597K
4
ZIM
Zacks Investment Management
Illinois
+$353K
5
MDCM
Morgan Dempsey Capital Management
Wisconsin
+$350K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$732K
2
WCM
Wallace Capital Management
Texas
-$482K
3
American Century Companies
American Century Companies
Missouri
-$345K
4
Northern Trust
Northern Trust
Illinois
-$156K
5
BIT
BlackRock Institutional Trust
California
-$81.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
ZIM
26
Zacks Investment Management
Illinois
$384K +$353K +6,465 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$355K +$10.9K +200 +3%
CIC
28
Crawford Investment Counsel
Georgia
$335K +$308K +5,640 New
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
$329K – – –
Deutsche Bank
30
Deutsche Bank
Germany
$322K +$119K +2,182 +67%
WCM
31
Wedge Capital Management
North Carolina
$315K +$10.9K +200 +4%
TA
32
Teton Advisors
New York
$308K – – –
NI
33
Numeric Investors
Massachusetts
$281K +$25.9K +474 +11%
HIM
34
Hillsdale Investment Management
Ontario, Canada
$262K +$240K +4,400 New
TA
35
Teachers Advisors
New York
$242K -$1.42K -26 -0.6%
Two Sigma Investments
36
Two Sigma Investments
New York
$238K -$10.9K -200 -5%
Morgan Stanley
37
Morgan Stanley
New York
$236K +$12.2K +224 +6%
Wells Fargo
38
Wells Fargo
California
$208K – – –
STC
39
SEI Trust Company
Pennsylvania
$202K -$5.46K -100 -3%
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$176K – – –
NFA
41
Nationwide Fund Advisors
Ohio
$156K +$8.13K +149 +6%
AIG
42
American International Group
New York
$132K -$2.29K -42 -2%
BA
43
BlackRock Advisors
Delaware
$130K +$109 +2 +0.1%
Invesco
44
Invesco
Georgia
$48K +$43.7K +800 New
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$44K – – –
PNC Financial Services Group
46
PNC Financial Services Group
Pennsylvania
$34K – – –
SO
47
STRS Ohio
Ohio
$30K – – –
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$30K +$5.35K +98 +25%
PCM
49
Prelude Capital Management
New York
$30K +$27.3K +500 New
CCMH
50
Cornerstone Capital Management Holdings
New York
$24K +$21.8K +400 New
1
2
3

UTMD Hedge Fund Activity: Q3 2013 in Review

60 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2013, worth a combined $139M — up 12% from $124M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new UTMD positions and 1 closed out — a net gain of 5 holders — while 22 added to existing stakes and 19 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $1.58M. The largest seller was Fidelity Investments, cutting an estimated $732K.

  • 60 institutional investors held Utah Medical Products (UTMD) as of Q3 2013, up from 55 in Q2 2013.
  • Funds reported $139M of Utah Medical Products stock for Q3 2013, up 12% quarter-over-quarter.
  • 6 funds opened new Utah Medical Products positions in Q3 2013 and 1 closed out, a net change of +5 holders.
  • The largest Utah Medical Products buyer in Q3 2013 was T. Rowe Price Associates, an estimated $1.58M added.
  • The largest Utah Medical Products seller in Q3 2013 was Fidelity Investments, an estimated $732K sold.

Based on aggregated 13F filings for Q3 2013.